These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 22406279)
1. Safety reporting in developing country vaccine clinical trials-a systematic review. Muehlhans S; Richard G; Ali M; Codarini G; Elemuwa C; Khamesipour A; Maurer W; Mworozi E; Kochhar S; Rundblad G; Vuitton D; Rath B Vaccine; 2012 May; 30(22):3255-65. PubMed ID: 22406279 [TBL] [Abstract][Full Text] [Related]
2. A systematic review of adverse events following immunization during pregnancy and the newborn period. Fulton TR; Narayanan D; Bonhoeffer J; Ortiz JR; Lambach P; Omer SB Vaccine; 2015 Nov; 33(47):6453-65. PubMed ID: 26413879 [TBL] [Abstract][Full Text] [Related]
3. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Bonhoeffer J; Kohl K; Chen R; Duclos P; Heijbel H; Heininger U; Jefferson T; Loupi E Vaccine; 2002 Dec; 21(3-4):298-302. PubMed ID: 12450705 [TBL] [Abstract][Full Text] [Related]
4. Reporting of vaccine safety data in publications: systematic review. Bonhoeffer J; Zumbrunn B; Heininger U Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):101-6. PubMed ID: 15386705 [TBL] [Abstract][Full Text] [Related]
5. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization. Kohl KS; Magnus M; Ball R; Halsey N; Shadomy S; Farley TA Vaccine; 2008 Nov; 26(50):6349-60. PubMed ID: 18805456 [TBL] [Abstract][Full Text] [Related]
7. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India. Joshi J; Das MK; Polpakara D; Aneja S; Agarwal M; Arora NK Indian J Pediatr; 2018 Feb; 85(2):139-148. PubMed ID: 29170922 [TBL] [Abstract][Full Text] [Related]
8. Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): a randomized controlled trial. Ateudjieu J; Stoll B; Nguefack-Tsague G; Tchangou C; Genton B Vaccine; 2014 Sep; 32(43):5662-8. PubMed ID: 25160064 [TBL] [Abstract][Full Text] [Related]
9. Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015. Lei J; Balakrishnan MR; Gidudu JF; Zuber PLF Vaccine; 2018 Mar; 36(12):1577-1582. PubMed ID: 29454518 [TBL] [Abstract][Full Text] [Related]
10. A systematic review of safety data reporting in clinical trials of vaccines against malaria, tuberculosis, and human immunodeficiency virus. Tamminga C; Kavanaugh M; Fedders C; Maiolatesi S; Abraham N; Bonhoeffer J; Heininger U; Vasquez CS; Moorthy VS; Epstein JE; Richie TL Vaccine; 2013 Aug; 31(35):3628-35. PubMed ID: 23395586 [TBL] [Abstract][Full Text] [Related]
11. Vaccinovigilance in Europe--need for timeliness, standardization and resources. Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918 [TBL] [Abstract][Full Text] [Related]
12. Adverse event reporting following immunization of hepatitis B vaccine: A 13-year review. Gong X; Fang Q; Zhong J; Zheng C; Yin Z Hum Vaccin Immunother; 2024 Dec; 20(1):2411824. PubMed ID: 39396824 [TBL] [Abstract][Full Text] [Related]
13. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study. Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B; Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547 [TBL] [Abstract][Full Text] [Related]
14. Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany. Muehlhans S; von Kleist M; Gretchukha T; Terhardt M; Fegeler U; Maurer W; Namazova-Baranova L; Gaedicke G; Baranov A; Rath B Paediatr Drugs; 2014 Aug; 16(4):321-30. PubMed ID: 24849291 [TBL] [Abstract][Full Text] [Related]
15. Adverse event following immunization (AEFI) surveillance in India, position paper of Indian Academy of Pediatrics,2013. Chitkara AJ; Thacker N; Vashishtha VM; Bansal CP; Gupta SG Indian Pediatr; 2013 Aug; 50(8):739-41. PubMed ID: 24036641 [TBL] [Abstract][Full Text] [Related]
16. Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013. Cheng DR; Perrett KP; Choo S; Danchin M; Buttery JP; Crawford NW Vaccine; 2015 Mar; 33(13):1602-7. PubMed ID: 25698493 [TBL] [Abstract][Full Text] [Related]
17. Surveillance of adverse events following immunisation: Australia 2002 to 2003. Lawrence G; Boyd I; McIntyre P; Isaacs D Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056 [TBL] [Abstract][Full Text] [Related]
18. Improving community based AEFI (Adverse Events Following Immunization) reporting rate through telephone "beep" in a Cameroon health district: a randomized field trial. Tsafack M; Ateudjieu J Pan Afr Med J; 2015; 22():351. PubMed ID: 26985269 [TBL] [Abstract][Full Text] [Related]